Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication-Reference-Cited by-同舟云学术

Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication

Published:2010-02 Issue:2 Volume:18 Page:413-420
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Zhong Xiao-Song,Matsushita Maiko,Plotkin Jason,Riviere Isabelle,Sadelain Michel

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression;Staveley-O'Carroll;Proc Natl Acad Sci USA,1998

2. T cell anergy;Schwartz;Annu Rev Immunol,2003

3. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells;Townsend;Science,1993

4. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway;Melero;Eur J Immunol,1998

5. Engagement of the OX-40 receptor in vivo enhances antitumor immunity;Weinberg;J Immunol,2000

Cited by 439 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges;Cancer Letters;2024-09

2. Molecular mechanism of co-stimulatory domains in promoting CAR-T cell anti-tumor efficacy;Biochemical Pharmacology;2024-09

3. Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells;Cellular and Molecular Life Sciences;2024-08-31

4. Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study;Leukemia;2024-08-27

5. Novel immunotherapeutics against LGR5 to target multiple cancer types;EMBO Molecular Medicine;2024-08-21